CP
XBI icon

Camelot Portfolios’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Camelot Portfolios’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Hold
0
– – – 605
2024
Q3 		– Sell
-2,130
Closed -$197K – 581
2024
Q2 		$197K Buy
+2,130
New +$191K 0.11% 176

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Camelot Portfolios's XBI Position: Q4 2025 in Review

Camelot Portfolios held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q4 2025 at 0 shares worth $8. The position accounts for ﹤0.01% of the portfolio, ranked #605.

Camelot Portfolios first reported a position in XBI in Q2 2024 and has held it in 1 quarter since. The position peaked at $197K in Q2 2024. 815 funds tracked by Wall St. Rank hold XBI as of Q4 2025.

  • Camelot Portfolios held 0 shares of State Street SPDR S&P Biotech ETF worth $8 as of Q4 2025.
  • Camelot Portfolios left its State Street SPDR S&P Biotech ETF share count unchanged in Q4 2025.
  • State Street SPDR S&P Biotech ETF made up ﹤0.01% of Camelot Portfolios's portfolio in Q4 2025, its #605 holding.
  • Camelot Portfolios first reported a position in State Street SPDR S&P Biotech ETF in Q2 2024 and has held it in 1 quarter since.
  • Camelot Portfolios's State Street SPDR S&P Biotech ETF position peaked at $197K in Q2 2024.
  • 815 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2025.

Based on Camelot Portfolios's 13F filing for Q4 2025, filed 29 Jan 2026.